Index: Vol 137 issue 3 June 2015 Gynecologic Oncology (journal) - not open access

Gynecologic Oncology Volume 137, Issue 3 ,  Pages 363-600, June 2015

Editorial Board

Editorial

The ideal adjuvant treatment in node positive vulvar cancer is (fill in your best guess here)    Pages 363-364 Mitchell Kamrava

Original Research Reports

Lead Article

Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis   Original Research Article Pages 365-372 Beant S. Gill, Mark E. Bernard, Jeff F. Lin, Goundappa K. Balasubramani, Malolan S. Rajagopalan, Paniti Sukumvanich, Thomas C. Krivak, Alexander B. Olawaiye, Joseph L. Kelley, Sushil Beriwal

Vulvar Cancer

Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review   Original Research Article Pages 373-379 Pierluigi Benedetti Panici, Federica Tomao, Lavinia Domenici, Andrea Giannini, Diana Giannarelli, Innocenza Palaia, Violante Di Donato, Angela Musella, Roberto Angioli, Ludovico Muzii

Vulvar and vaginal reconstruction using the “angel wing” perforator-based island flap   Original Research Article Pages 380-385 Sang Wha Kim, Won Moo Lee, Jeong Tae Kim, Youn Hwan Kim

Ovarian Cancer

A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation — An NRG Oncology/Gynecologic Oncology Group study   Original Research Article Pages 386-391 Robert L. Coleman, Michael W. Sill, Katherine Bell-McGuinn, Carol Aghajanian, Heidi J. Gray, Krishnansu S. Tewari, Steven C. Rubin, Thomas J. Rutherford, John K. Chan, Alice Chen, Elizabeth M. Swisher

Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective review   Original Research Article Pages 392-400 Dana M. Roque, Elena S. Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz, Wendelin K. Nelson, Alessandro D. Santin

Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer   Original Research Article Pages 401-405 Naima Joseph, Rachel M. Clark, Don S. Dizon, Malinda S. Lee, Annekathryn Goodman, David Boruta, John O. Schorge, Marcela G. del Carmen, Whitfield B. Growdon

Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery   Original Research Article Pages 406-411 Pierluigi Benedetti Panici, Violante Di Donato, Margherita Fischetti, Assunta Casorelli, Giorgia Perniola, Angela Musella, Claudia Marchetti, Innocenza Palaia, Pasquale Berloco, Ludovico Muzii

The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study   Original Research Article Pages 412-417 Dong Hoon Suh, Jeong-Yeol Park, Jung-Yun Lee, Byoung-Gie Kim, Myong Cheol Lim, Jae-Weon Kim, Duk-Soo Bae, Sang-Yoon Park, Joo-Hyun Nam, Kidong Kim, Jae Hong No, Yong-Beom Kim

Ovarian Germ Cell Tumors

Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors   Original Research Article Pages 418-422 Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam

Cancer Genetics and Biomarkers

The sooner the better: Genetic testing following ovarian cancer diagnosis   Original Research Article Pages 423-429 E. Fox, J. McCuaig, R. Demsky, C. Shuman, D. Chitayat, M. Maganti, J. Murphy, B. Rosen, S. Ferguson, S. Randall Armel

Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates   Original Research Article Pages 430-435 John B. Liao, Yuen Yee Yip, Elizabeth M. Swisher, Kathy Agnew, Karl Erik Hellstrom, Ingegerd Hellstrom

Uterine Cancer

Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer   Original Research Article Pages 436-442 J. How, W.H. Gotlieb, J.Z. Press, J. Abitbol, M. Pelmus, A. Ferenczy, S. Probst, R. Gotlieb, S. Brin, S. Lau Graphical abstract

Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature   Original Research Article Pages 443-447 Marie Plante, Omar Touhami, Xuan-Bich Trinh, Marie-Claude Renaud, Alexandra Sebastianelli, Katherine Grondin, Jean Gregoire

Circadian actigraphic rest–activity rhythms following surgery for endometrial cancer: A prospective, longitudinal study   Original Research Article Pages 448-455 Meredith E. Rumble, Stephen L. Rose, Kaitlin Hanley White, A. Holliston Moore, Philip Gehrman, Ruth M. Benca, Erin S. Costanzo

Epithelioid trophoblastic tumor: A single institution case series at the New England Trophoblastic Disease Center   Original Research Article Pages 456-461 M.R. Davis, B.E. Howitt, B.J. Quade, C.P. Crum, N.S. Horowitz, D.P. Goldstein, R.S. Berkowitz

Cervical Cancer

A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study   Original Research Article Pages 462-467 Chun-Chieh Wang, Hung-Hsueh Chou, Lan-Yan Yang, Hao Lin, Wen-Shiung Liou, Chih-Wen Tseng, Feng-Yuan Liu, Jui-Der Liou, Kuan-Gen Huang, Huei-Jean Huang, Eng-Yen Huang, Chien-Hsun Chen, Ting-Chang Chang, Chee-Jen Chang, Ji-Hong Hong, Chyong-Huey Lai

Primary surgery versus primary radiation therapy for FIGO stages I–II small cell carcinoma of the uterine cervix: A retrospective Taiwanese Gynecologic Oncology Group study   Original Research Article Pages 468-473 Tze-Chien Chen, Huei-Jean Huang, Tao-Yeuan Wang, Lan-Yan Yang, Chi-Hau Chen, Ya-Min Cheng, Wen-Hsiung Liou, Shih-Tien Hsu, Kuo-Chang Wen, Yu-Che Ou, Yao-Ching Hung, Hung-Cheng Lai, Chih-Ming Ho, Ting-Chang Chang

The prognostic significance of histologic type in early stage cervical cancer – A multi-institutional study   Original Research Article Pages 474-478 Ira Winer, Isabel Alvarado-Cabrero, Oudai Hassan, Quratulain F. Ahmed, Baraa Alosh, Sudeshna Bandyopadhyay, Sumi Thomas, Samet Albayrak, Shobhana Talukdar, Zaid Al-Wahab, Mohamed A. Elshaikh, Adnan Munkarah, Robert Morris, Rouba Ali-Fehmi

Health Services Research

Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population   Original Research Article Pages 479-484 G.K. Forde, J. Chang, A. Ziogas, K. Tewari, R.E. Bristow

Patterns and utility of routine surveillance in high grade endometrial cancer   Original Research Article Pages 485-489 Jessica Hunn, Meaghan E. Tenney, Ana I. Tergas, Erin A. Bishop, Kathleen Moore, William Watkin, Carolyn Kirschner, Jean Hurteau, Gustavo C. Rodriguez, Ernst Lengyel, Nita K. Lee, S. Diane Yamada

A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer   Original Research Article Pages 490-496 Lindsey E. Minion, Jiaru Bai, Bradley J. Monk, L. Robin Keller, Eskander N. Ramez, Gareth K. Forde, John K. Chan, Krishnansu S. Tewari

Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center   Original Research Article Pages 497-502 Sarah M. Temkin, Saroj A. Fleming, Selma Amrane, Nicholas Schluterman, Mishka Terplan

Selective cardiac surveillance in patients with gynecologic cancer undergoing treatment with pegylated liposomal doxorubicin (PLD)   Original Research Article Pages 503-507 C.L. Kushnir, A.M. Angarita, L.J. Havrilesky, S. Thompson, D. Spahlinger, A.K. Sinno, E.J. Tanner, A.A. Secord, K.L. Roche, R.L. Stone, A.N. Fader

Quality of Life

Feasibility of a lifestyle intervention for overweight/obese endometrial and breast cancer survivors using an interactive mobile application   Original Research Article Pages 508-515 Michele L. McCarroll, Shannon Armbruster, Rachael J. Pohle-Krauza, Amy M. Lyzen, Sarah Min, David W. Nash, G. Dante Roulette, Stephen J. Andrews, Vivian E. von Gruenigen

Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial   Original Research Article Pages 516-522 Jannah Baker, Monika Janda, Nick Graves, Judy Bauer, Merrilyn Banks, Andrea Garrett, Naven Chetty, Alex J. Crandon, Russell Land, Marcelo Nascimento, James L. Nicklin, Lewis C. Perrin, Andreas Obermair

Post-operative enteral immunonutrition for gynecologic oncology patients undergoing laparotomy decreases wound complications   Original Research Article Pages 523-528 J.S. Chapman, E. Roddy, G. Westhoff, E. Simons, R. Brooks, S. Ueda, L. Chen

Translational Science

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma   Original Research Article Pages 529-537 Per-Henrik D. Edqvist, Jutta Huvila, Bjorn Forsstrom, Lauri Talve, Olli Carpen, Helga B. Salvesen, Camilla Krakstad, Seija Grenman, Henrik Johannesson, Oscar Ljungqvist, Mathias Uhlen, Fredrik Ponten, Annika Auranen

The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition   Original Research Article Pages 538-545 Tomohiko Fukuda, Katsutoshi Oda, Osamu Wada-Hiraike, Kenbun Sone, Kanako Inaba, Yuji Ikeda, Aki Miyasaka, Tomoko Kashiyama, Michihiro Tanikawa, Takahide Arimoto, Hiroyuki Kuramoto, Tetsu Yano, Kei Kawana, Yutaka Osuga, Tomoyuki Fujii

PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer   Original Research Article Pages 546-552 Ruiqiong Ma, Xue Ye, Hongyan Cheng, Yu Ma, Heng Cui, Xiaohong Chang

Reviews

Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care   Review Article Pages 553-558 Natalia Rodriguez Gomez-Hidalgo, Bertha Alejandra Martinez-Cannon, Alpa M. Nick, Karen H. Lu, Anil K. Sood, Robert L. Coleman, Pedro T. Ramirez

Epithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescription   Review Article Pages 559-573 Rikki A. Cannioto, Kirsten B. Moysich

Immediate radical trachelectomy versus neoadjuvant chemotherapy followed by conservative surgery for patients with stage IB1 cervical cancer with tumors 2 cm or larger: A literature review and analysis of oncological and obstetrical outcomes   Review Article Pages 574-580 Rene Pareja, Gabriel J. Rendon, Monica Vasquez, Lina Echeverri, Carlos Millan Sanz-Lomana, Pedro T. Ramirez

Uterine carcinosarcoma: A review of the literature   Review Article Pages 581-588 Leigh A. Cantrell, Stephanie V. Blank, Linda R. Duska

Surgical Film

Controlled removal of a large uterus within a bowel bag and morcellation in the bowel bag from the vagina    Pages 589-590 Diana English, Gulden Menderes, Masoud Azodi

Winter Meeting Abstracts

Abstract 1: Gynecologic oncologists as benign gynecologic surgeons    Pages 591 W. Baker, E. Chang, E. Pelkofski, L. Duska

Abstract 2: Prognostic significance of POLE exonuclease domain mutations in high grade endometrioid endometrial cancer on survival and recurrence    Pages 591-592 C.C. Billingsley, E.M. Hade, D.E. Cohn, D.G. Mutch, P.J. Goodfellow

Abstract 3: Inhibition of STAT3 in ovarian clear cell carcinoma results in decreased cell proliferation and induction of apoptosis    Pages 592 K. Bixel, U. Saini, J. Fowler, S. Rajendiran, R. Wanner, K. Hideg, D.E. Cohn, S. Karuppaiyah

Abstract 4: Differential gene expression associated with Lynch syndrome in patients less than and over 60 years of age with endometrial adenocarcinoma    Pages 592 O. Dziadek, B. Shoup, K. Williams

Abstract 5: Evaluation of universal immunohistochemistry screening for diagnosing Lynch syndrome in endometrial cancer patients at a tertiary care center    Pages 592-593 E.G. Hartnett, A. Stuckey, C. McCourt

Abstract 6: Proposed algorithm for the management of age 21 and older undergoing primary cervical cancer screening using primary HPV testing with cytology or colposcopy triage: A decision analysis    Pages 593 N. Joseph, R. Pilliod, R. Clark, A. Goodman, W. Growdon

Abstract 7: Impact of age on 30-day mortality and morbidity in patients undergoing surgery for endometrial cancer    Pages 593 K. Maurer, H. Mahdi

Abstract 8: The effects of obesity on oncologic outcomes in patients with ovarian cancer    Pages 593-594 M. McDonald, A. O’Shea, M. Goodheart, D. Bender, J. Gonzalez Bosquet, A. Button, J. Stephan

Abstract 9: Low utility of cytology screening for other lower genital tract neoplasia (LGTN) following chemoradiation (CRT) for cervical cancer (CxCA)    Pages 594 S. Park, C. Holschneider, M. Amneus

Abstract 10: Does routine post-treatment PET/CT add value to the care of women with locally advanced cervical cancer?    Pages 594-595 N.T. Phippen, L.J. Havrilesky, J.C. Barnett, C.A. Hamilton, M. Stany, W.J. Lowery

Abstract 11: Morcellation and the incidence of occult malignancy: a dual-institution review    Pages 595 T. Picerno, M. Wasson, M. Hoffman, M.E. Borowsky

Abstract 12: Perioperative blood transfusion in gynecologic surgery    Pages 595 L. Prescott, T. Aloia, A. Brown, J. Taylor, C. Sun, C. Levenback, K. Schmeler, D. Bodurka

Abstract 13: Trends in treatment of uterine serous cancer in the medicare population    Pages 595-596 JA Rauh-Hain, S. Connor, J.B. Clemmer, R.M. Clark, T. Hall, W.B. Growdon, A.K. Goodman, D. Boruta, J.O. Schorge, M.G. del Carmen

Abstract 14: Glutamine supports ovarian cancer cell proliferation through modulation of the mTOR/S6 pathway    Pages 596 D.R. Roque, L. Yuan, W.Z. Wysham, C. Zhou, V. Bae-Jump

Abstract 15: Cancer-related fatigue in gynecologic oncology patients undergoing chemotherapy    Pages 596 K. Shields, C. Craig, L. Baxter, L. Renda, J. Pipe, B. Monk, D. Chase

Abstract 16: Multimodal pain control is associated with reduced hospital stay following open abdominal hysterectomy    Pages 596 M. Ulm, J. Santoso, B. Jennings, J. Wan

Abstract 17: Knowledge of risk factors associated with endometrial cancer in a general gynecologic population    Pages 597 C. Washington, W. Ronner, P. Neff, A. Haggerty, E. Ko

Abstract 18: Overa: a prediction tool using serum calcium to discriminate malignant from benign pelvic masses    Pages 597 S.S. Winkler, M.G. Kelly, S.S. Lentz, S.H. Berliner, M.F. Swain, H.G. Skinner, G.G. Schwartz

Evaluation of three predictive models assessing debulkability of patients with advanced ovarian, fallopian tube, or primary peritoneal cancer    Pages 597-598 C. Stashwick, L. Cory, M. Kelly

Making the case for salpingectomy as the elective sterilization procedure: A decision analysis    Pages 598 S. Dilley, A. Allen, C. Lessard-Anderson, J. Bakkum-Gamez, Koenraad De Geest, A.B. Caughey, M.I. Rodriguez

Effect of preoperative chemotherapy on postoperative morbidity and mortality in patients undergoing surgery for ovarian cancer    Pages 598-599 D. Doo, M. Guy, K. Behbakht, S. Davidson, J. Sheeder, S. Guntupalli

Lymphocyte nadir and reconstitution during chemotherapy predicts survival in ovarian cancer patients    Pages 599 R. Brightwell, K. Eng, S. Lele, P. Frederick, S. Akers, A. Odunsi

Impact of age on 30-day mortality and morbidity in patients undergoing surgery for ovarian cancer    Pages 599 A. Wiechert, P. Rose, H. Mahdi

Erratum

Erratum to “Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: A review” [Gynecol. Oncol. 136 (2015) 384–388]    Pages 600 Omar Touhami, Marie Plante